The Contract Development and Manufacturing Organization (CDMO) industry in India is a fast-growing segment of the pharmaceutical sector that provides outsourced drug development and manufacturing ...

Controlling drug-to-antibody ratio and scalable reactors are key to reliable antibody-drug conjugate manufacturing success.

Earnings call Codexis reported Q4 2025 revenue of $38.9M (up 81% YoY), with full-year revenue rising 19% to $70.4M. Product gross margin improved to 64% (from 56% prior year). 2026 revenue is guided ...

Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025 Ended year with $78.2 million in cash, cash equivalents and short-term investments, runway ...

Holland & Barrett’s Global Production Centre is rapidly redefining what contract manufacturing looks like in the health and ...

W. L. Gore & Associates (Gore) is collaborating with customized ligand partners to introduce a new range of high-performance affinity membrane chromatography products. This initiative expands Gore’s ...

W. L. Gore Associates (Gore) is collaborating with customized ligand partners to introduce a new range of high-performance affinity membrane chromatography products. This initiative expands Gore's pre ...

The company expects 2026 revenue in the range of $72 million to $76 million, with revenue "more heavily weighted towards the second half of 2026 versus the first half." Moore asserted, "Our goals for ...

Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess ® enterprise ...